September 6, 2019 – Pittsburgh, PA PANTHERx Rare Pharmacy has issued a Request for Information (RFI) for a Pharmacy Management System (PMS) that would replace the current digital …
PANTHERx Rare Pharmacy announces that it has, for a 4th time, been named to the Inc. 5000 list, celebrating the fastest-growing private companies in America. PANTHERx is being recognized on …
Read the original Press Release. Today, PANTHERx modernized its identity with a new name that corresponds to its laser focus on innovating on behalf of patients that suffer from rare …
PANTHERx is delighted to announce that we are a winner of the 2019 Pittsburgh Business Times Best Places to Work Award. Over the past year PANTHERx has experienced tremendous growth …
Click here to read the full press release. As the medical community has learned more about rare diseases and the complex medications and models used to treat rare disease …
As part of the PANTHERx Specialty Pharmacy Fellowship Program, our 2018-2019 fellows, Olivia Goss, Pharm.D., and Brandon Barry, Pharm.D., conducted research and presented their findings at the 2019 AMCP Conference. …
PANTHERx Specialty Pharmacy, the industry leading independent national specialty pharmacy, has been selected by Paratek Pharmaceuticals, Inc. as a limited pharmacy network provider of its new once-daily oral antibiotic, Nuzyra™ …
Last week PANTHERx participated in the 2019 Asembia Specialty Pharmacy Summit in Las Vegas, NV, where we met with partners, announced strategic collaborations, unveiled the new PANTHERx brand, and shared …
We are excited to announce that PANTHERx Specialty Pharmacy has been selected as a finalist in the category of Retail/Independent/Hospital and Health System Specialty Pharmacies for the 2019 Specialty Pharmacy …
PANTHERx Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, unveiled a new, sophisticated and modern brand identity today while simultaneously announcing a new, state-of-the-art third location. This past year. PANTHERx continued …
